Success Stories: EB-1A Approved for Postdoctoral Research Fellow in Texas in the Field of Biology
On March 2, 2015, We Received Another EB1-A (Alien of Extraordinary Ability) Approval for a Postdoctoral Research Fellow in the Field of Biology (Approval Notice)
Position at the Time of Case Filing: Postdoctoral Research Fellow
Country of Origin: China
Service Center: Texas Service Center (TSC)
State of Residence at the Time of Filing: Texas
Approval Notice Date: March 2nd, 2015
Processing Time: 31 Days (13 Days After Premium Processing Requested)
In this case we were offered the opportunity to work with a biologist from China whose highly specialized work focused on characterizing the structural features of biologically significant transporter proteins. She had produced 4 peer-reviewed journal articles and attended two meetings with poster presentations; altogether our client’s work had received no fewer than 398 citations from independent and leading researchers at prestigious institutions and organizations around the world, showing its major significance within her field. She had also reviewed 15 manuscripts for 4 prominent, internationally-circulated journals. An independent recommender endorsed our client’s superior level of expertise: “[Client’s] work in examining the structure and function of these membrane proteins, along with their affiliations to deadly pathogens that cause lethal human illnesses, is a critical asset that can be used for designing pharmaceutical countermeasures that are conscious of these structures so that they can overtake molecules within that structure and manipulate them to deliver said drugs to the site of bacterial infection.” It was our goal to prove that our client qualified for classification as an Alien of Extraordinary Ability given that she sought to remain in the United States to continue work in the area of Biology, and that her continued research would substantially and prospectively benefit the United States. With the proof and documentation that we provided, her case was approved in just 31 days.